Boumpas DT - Search Results

1

Low dose of infliximab is inadequate in most patients with spondylarthropathies.

Sidiropoulos P, Kritikos HD, Siakka P, Mamoulaki M, Kouroumali H, Voudouris K, Boumpas DT. Sidiropoulos P, et al. Among authors: boumpas dt. Clin Exp Rheumatol. 2005 Jul-Aug;23(4):513-6. Clin Exp Rheumatol. 2005. PMID: 16095121 Clinical Trial.

2

Perspective on future therapy of vasculitis.

Boumpas DT, Kritikos HD, Daskalakis NG. Boumpas DT, et al. Curr Rheumatol Rep. 2000 Oct;2(5):423-9. doi: 10.1007/s11926-000-0043-5. Curr Rheumatol Rep. 2000. PMID: 11123093 Review.

3

Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect.

Papadaki HA, Kritikos HD, Gemetzi C, Koutala H, Marsh JC, Boumpas DT, Eliopoulos GD. Papadaki HA, et al. Among authors: boumpas dt. Blood. 2002 Mar 1;99(5):1610-9. doi: 10.1182/blood.v99.5.1610. Blood. 2002. PMID: 11861275 Free article.

4

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy.

Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Papadaki HA, et al. Among authors: boumpas dt. Blood. 2002 Jul 15;100(2):474-82. doi: 10.1182/blood-2002-01-0136. Blood. 2002. PMID: 12091338 Free article. Clinical Trial.

5

Non-Hodgkin's lymphoma in patients with systemic lupus erythematosus.

Papadaki HA, Xylouri I, Katrinakis G, Foudoulakis A, Kritikos HD, Stathopoulos EN, Boumpas DT, Eliopoulos GD. Papadaki HA, et al. Among authors: boumpas dt. Leuk Lymphoma. 2003 Feb;44(2):275-9. doi: 10.1080/1042819021000030045. Leuk Lymphoma. 2003. PMID: 12688345

6

Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit.

Sidiropoulos P, Bertsias G, Kritikos HD, Kouroumali H, Voudouris K, Boumpas DT. Sidiropoulos P, et al. Among authors: boumpas dt. Ann Rheum Dis. 2004 Feb;63(2):144-8. doi: 10.1136/ard.2003.015933. Ann Rheum Dis. 2004. PMID: 14722202 Free PMC article. Clinical Trial.

7

Sequential therapies with intravenous cyclophosphamide and oral mycophenolate mofetil or azathioprine are efficacious and safe in proliferative lupus nephritis.

Boumpas DT. Boumpas DT. Clin Exp Rheumatol. 2004 May-Jun;22(3):276-7. Clin Exp Rheumatol. 2004. PMID: 15144119 No abstract available.

8

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.

Sidiropoulos PI, Boumpas DT. Sidiropoulos PI, et al. Among authors: boumpas dt. Lupus. 2004;13(5):391-7. doi: 10.1191/0961203304lu1032oa. Lupus. 2004. PMID: 15230298 Review.

9

Ear-nose-throat manifestations of autoimmune rheumatic diseases.

Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Papadimitraki ED, et al. Among authors: boumpas dt. Clin Exp Rheumatol. 2004 Jul-Aug;22(4):485-94. Clin Exp Rheumatol. 2004. PMID: 15301251 Review.

10

Intestinal ischemia as the first manifestation of vasculitis.

Passam FH, Diamantis ID, Perisinaki G, Saridaki Z, Kritikos H, Georgopoulos D, Boumpas DT. Passam FH, et al. Among authors: boumpas dt. Semin Arthritis Rheum. 2004 Aug;34(1):431-41. doi: 10.1016/j.semarthrit.2003.12.004. Semin Arthritis Rheum. 2004. PMID: 15305242 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters